Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.56, No.4, p.331-334, 2009 |
||
Title: Low frequency mutation of the Ephrin receptor A3 gene in hepatocellular carcinoma | ||
Author: H. J. BAE, J. H. SONG, J. H. NOH, J. K. KIM, K. H. JUNG, J. W. EUN, H. J. XIE, J. C. RYU, Y. M. AHN, S. Y. KIM, S. H. LEE, N. J. YOO, J. Y. LEE, W. S. PARK, S. W. NAM | ||
Abstract: EphA3 is a component of the Eph/ephrin tyrosine kinase system, which participates in vasculature development. This receptor/ligand system is associated with various signaling pathways related to cell growth and viability, cytoskeletal organization, cell migration, and anti-apoptosis. Accumulated evidence suggests that aberrant regulation of EphA3 and its genetic alterations are implicated in the development and progression of various cancers. However, despite a high incidence of EphA3 over-expression, no such investigation has been performed in hepatocellular carcinoma. Thus, we investigated genetic alterations of the EphA3 gene in 73 cases of hepatocellular carcinoma by single-strand conformational polymorphism and sequencing. One novel D219V missense mutation was found in the extracellular domain of EphA3, and two genetic alterations in the intracellular sterile-α-motif (SAM) domain of EphA3 appeared to be polymorphisms. Although the functional assessments of this mutant are incomplete, it is believed that this novel EphA3 mutation may contribute to the development of hepatocellular carcinoma. |
||
Keywords: Eph receptor, EphA3, hepatocellular carcinoma, mutation | ||
Year: 2009, Volume: 56, Issue: 4 | Page From: 331, Page To: 334 | |
doi:10.4149/neo_2009_04_331 |
||
|
download file |
|